CLINICAL AND ECONOMIC EVALUATION OF THROMBOPOIETIN RECEPTOR AGONISTS IN THE TREATMENT OF CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA IN ADULTS

Aim. Hospital-based economic analysis for the use of thrombopoietin receptor agonists (TRA) Eltrombopag and Romiplostim has been performed in patients with chronic idiopathic thrombocytopenic purpura (ITP) at the background failure of previous treatment options. Materials and methods. Two models for...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: E. A. Pyadushkina, M. Yu. Frolov, M. V. Avksentyeva
Формат: Artigo
Язык:Russo
Опубликовано: IRBIS LLC 2016-02-01
Серии:Фармакоэкономика
Предметы:
idiopathic thrombocytopenic purpura (itp)
cost-minimization analysis
budget impact analysis
thrombopoietin receptor agonist (tpo-ra)
eltrombopag
romiplostim
Online-ссылка:https://www.pharmacoeconomics.ru/jour/article/view/130
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы